Toggle navigation
Home
Search
Services
Blog
Contact
About
CD4 Based in Vivo Imaging Agent for HIV 1 Infection
Allaway, Graham P.
Progenics Pharmaceuticals, Inc., Tarrytown, NY, United States
Search 16 grants from Graham Allaway
Search grants from Progenics Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Clinical and translational evaluation of vector saliva based vaccination strategies for Zika and other important or emerging vector-borne diseases
Kansas Implementation Project for Prev Secondary Conditions & Promoting the Hlth
The Influence of Ion Channels on Corneal Wound Healing
Longitudinal Course of Borderline Personality Disorder
SBIR Phase I: CVD Growth of Silicon Nanocables Using Patterned Silicon Dioxide Mask
Recently added grants:
Mechanisms of lipid droplet organization and functional diversification
Generating Evidence on Deprescribing Safety
SULT4a1, a novel neuroprotective protein in stroke
Deep tensor genomic imputation
Trans-omic analysis of epicardial adipose tissue in atrial fibrillation
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44AI036028-02A1
Application #
2004110
Study Section
Special Emphasis Panel (ZRG7-SSS-4 (02))
Project Start
1994-05-01
Project End
1998-09-29
Budget Start
1996-09-30
Budget End
1997-09-29
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Progenics Pharmaceuticals, Inc.
Department
Type
DUNS #
945494490
City
Tarrytown
State
NY
Country
United States
Zip Code
10591
Related projects
NIH 1997
R44 AI
CD4 Based in Vivo Imaging Agent for HIV 1 Infection
Allaway, Graham P. / Progenics Pharmaceuticals, Inc.
NIH 1996
R44 AI
CD4 Based in Vivo Imaging Agent for HIV 1 Infection
Allaway, Graham P. / Progenics Pharmaceuticals, Inc.
Comments
Be the first to comment on Graham Allaway's grant